Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,744 | 374 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,040 | 70 | $0 (2024) |
| Lilly USA, LLC | $872.78 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $634.65 | 28 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $608.98 | 21 | $0 (2024) |
| PFIZER INC. | $410.89 | 24 | $0 (2024) |
| Neurocrine BioSciences, Inc. | $356.82 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $312.00 | 17 | $0 (2024) |
| Abbott Laboratories | $283.91 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $263.58 | 14 | $0 (2024) |
| Amgen Inc. | $263.37 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,437 | 64 | ABBVIE INC. ($296.47) |
| 2023 | $1,950 | 95 | ABBVIE INC. ($312.80) |
| 2022 | $1,937 | 110 | ABBVIE INC. ($316.26) |
| 2021 | $2,420 | 105 | Lilly USA, LLC ($251.39) |
All Payment Transactions
374 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Diabetes Care | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $116.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Neurology | ||||||
| 09/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.83 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Cardio-renal | ||||||
| 06/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 255 | 321 | $66,463 | $11,154 |
| 2022 | 8 | 274 | 366 | $67,158 | $15,286 |
| 2021 | 8 | 269 | 364 | $66,641 | $14,785 |
| 2020 | 10 | 447 | 548 | $100,961 | $36,585 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 157 | $32,813 | $5,035 | 15.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 36 | $5,112 | $1,354 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 33 | 33 | $7,425 | $1,332 | 17.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 14 | 14 | $1,148 | $1,061 | 92.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 47 | $13,207 | $957.37 | 7.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $6,102 | $956.16 | 15.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $656.00 | $458.88 | 70.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 192 | $40,128 | $7,345 | 18.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 18 | 18 | $2,070 | $2,054 | 99.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 40 | $5,680 | $1,607 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 44 | $12,364 | $1,543 | 12.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 12 | 12 | $960.00 | $822.48 | 85.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 29 | 29 | $1,189 | $794.94 | 66.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $4,275 | $793.83 | 18.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $492.00 | $325.68 | 66.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 182 | $38,038 | $6,884 | 18.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 66 | $9,372 | $2,491 | 26.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 35 | $9,835 | $1,444 | 14.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $1,265 | $1,265 | 100.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 17 | 17 | $1,190 | $1,105 | 92.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 16 | 16 | $5,424 | $1,013 | 18.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 20 | 20 | $820.00 | $316.56 | 38.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 17 | $697.00 | $267.46 | 38.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 139 | 236 | $49,324 | $13,002 | 26.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 64 | 64 | $21,696 | $8,960 | 41.3% |
About Audra Mccall, PAC
Audra Mccall, PAC is a Physician Assistant healthcare provider based in Broken Arrow, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306845524.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Audra Mccall, PAC has received a total of $7,744 in payments from pharmaceutical and medical device companies, with $1,437 received in 2024. These payments were reported across 374 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($7,744).
As a Medicare-enrolled provider, Mccall has provided services to 1,245 Medicare beneficiaries, totaling 1,599 services with total Medicare billing of $77,811. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Broken Arrow, OK
- Active Since 07/19/2005
- Last Updated 08/31/2010
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1306845524
Products in Payments
- VRAYLAR (Drug) $538.94
- JARDIANCE (Drug) $444.34
- FARXIGA (Drug) $413.88
- INGREZZA (Drug) $356.82
- TRINTELLIX (Drug) $312.00
- EMGALITY (Drug) $296.86
- SPRAVATO (Drug) $230.88
- ELIQUIS (Drug) $228.94
- QULIPTA (Drug) $228.80
- REXULTI (Drug) $223.77
- XARELTO (Drug) $219.59
- Kerendia (Drug) $212.58
- ENTRESTO (Drug) $189.58
- MOUNJARO (Drug) $185.87
- TRULICITY (Drug) $174.28
- BELSOMRA (Drug) $173.12
- SOLIQUA 100/33 (Biological) $165.28
- FREESTYLE LIBRE 3 (Device) $158.89
- INVEGA SUSTENNA (Drug) $158.51
- BREZTRI (Drug) $150.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Broken Arrow
Ms. Kathy Huynh, Pa-C, PA-C
Physician Assistant — Payments: $6,092
Jacob Callison, Pa, PA
Physician Assistant — Payments: $5,755
Robbie Bollinger, Pa-C, PA-C
Physician Assistant — Payments: $4,356
Natalie Scardino, Pa,C, PA,C
Physician Assistant — Payments: $3,768
Corinne Onigbinde, Pa-C, PA-C
Physician Assistant — Payments: $1,040
Thuc-Vi Nguyen, Pa-C, PA-C
Physician Assistant — Payments: $832.50